AzTrials
AzTrials

BlindnessNCT05144906

Implicit Attitudes Toward Body Shape Among Blind Women

An observational study of Blindness and Implicit Bias, run by University of Haifa at 1 site in Israel.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

High levels of body image concerns and disordered eating in western women have been associated with the promotion of an unrealistically thin body ideal. The pressure to conform with the thin-ideal forms both explicit and implicit attitudes favoring thinness. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Blindness, Implicit Bias
How many people
64 participants
Where
1 siteIsrael
Study dates
1 Dec 2021to 15 Jun 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: The blind women group will only include women who were blinded earlier than the age of 7 and cannot see themselves in the mirror not recognize other people's faces or bodies or use visual-based media. The sighted women group will include women with normal or corrected-to-normal vision.

Who may be able to join

  • Aged 18-45 years.
  • Congenitally blind or blinded no later than the age of 7.
  • Inability to see themselves in the mirror.
  • Inability to recognize other people's faces or bodies.
  • Inability to use visual-based media.
  • Fluent English speakers.
Show all 9Show fewer
  • Aged 18-45 years old.
  • Corrected or corrected-to-normal vision.
  • Fluent English speakers.

Who cannot join

  • Any condition that prevents the ability to use a computer.
  • Sighted women
  • Any condition that prevents the ability to use a computer.

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • University of Haifa

    Haifa, Central District, 3600100

Other trials in Israel

About this study

Official title: Implicit Attitudes Toward Body Shape Among Blind Women: Evidence From an Auditory Implicit Association Test

High levels of body image concerns and disordered eating in western women have been associated with the promotion of an unrealistically thin body ideal. The pressure to conform with the thin-ideal forms both explicit and implicit attitudes favoring thinness. Visual-based media depicting thin-idealized bodies plays a major role in forming such attitudes. However, attitudes favoring thinness can also be transmitted through non-visual communication such as peer pressure and significant others. The current study will examine if implicit attitudes favoring thinness and disliking overweight bodies can be formed without ever being exposed to visual-based media or being visually exposed to body shapes. To achieve this goal, the study will assess implicit attitudes towards thin and overweight bodies in congenitally blind women and those who were blinded early in life. The assessment will be carried out using a novel auditory weight-bias implicit association test.

Read the detailed description

Previous studies have demonstrated strong implicit associations between images portraying thin bodies and positive words and images portraying overweight bodies and negative words among healthy individuals in Western society. This so-called "implicit weight bias" is thought to represent individuals' unconscious or automatic stereotypical attitudes against being overweight. The goal of the current study is to examine implicit weight biases among congenitally blind as well as sighted women using a novel auditory version of the weight bias implicit association task. In this task, participants hear a series of words and are requested to classify each word using a motor response to the matching category. The categories used will be negative and positive words as well as words describing thin and overweight bodies. Implicit anti-fat bias is reflected by longer response times and higher error rates, when positive words and those describing overweight bodies require the same motor response and when negative words are coupled with words describing thin bodies compared to when positive and negative words are coupled with words describing thin and overweight bodies, respectively.

The investigators have collected preliminary results in a sample of blind women (N = 18) in Israel. The investigators plan to a) expand the data collection in Israel to reach a sample of 30 blind women and to b) carry out a full replication of the study in an independent sample of blind and sighted women in the US. Data have not been collected yet for the US replication study. Based on the effect size of the the implicit bias effect (represented by the IAT D score) obtained in preliminary results in the Israeli sample (Cohen's D = 0.74), a power analysis using G*power was carried out and showed that a sample of 22 participants is sufficient to detect the IAT implicit bias effect with a power > 95% and an a-priori alpha set at 0.05.

Based on preliminary results in the Israeli sample, it is hypothesized that:

  1. Blind women will demonstrate an implicit bias indicating preference for thin bodies and a dislike of overweight bodies. This effect will be reflected by slower response times when words describing thin bodies will be coupled with negative compared to positive words and when words describing overweight bodies will be coupled with positive compared to negative words. This implicit bias effect will be computed using the IAT's D algorithm.
  2. The implicit anti-fat bias effect (IAT D-score) will be comparable between sighted and blind women.
Medical subject headings
Blindness, Bias, Implicit

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT05144906
Study groupRoleWhat they receive
Blind womenThe blind women group will include women who are congenitally blind or that were blinded early in life (up to the age of 7).
Sighted womenWomen with normal or corrected-to-normal eye sight.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Implicit Association Test

    IAT D-Score calculated for assessing an implicit weight bias. The IAT D score will be computed using the improved algorithm suggested by Greenwald et al. (2003). According to this algorithm, RTs longer than 10,000 ms will be deleted. Participants with more than 10% of the trials that are shorted than 300 ms will be excluded from the analysis. Mean RTs for correct trials will be computed for each block separately. Error trials will be replaced by the mean score of each block + 600 ms. Then, the difference in RTs between the practice stereotype incongruent and practice congruent conditions will be divided by their pooled SD. Then, the different in RTs between the test stereotype congruent and incongruent blocks will be divided by their pooled RTs. Lastly, the two scores form the practice and test blocks will be averaged to compute the IAT D score.

    Measured: One assessment at baseline after study information and informed consent was given

Secondary outcomes (4)
  1. Sociocultural Attitudes Toward Appearance Questionnaire-4 (SATAQ-4R)

    The SATAQ-4R is a gender-specific self-report tool composed of 31 items in the female version. It includes four scales to evaluate the perceived pressure from family, peers, significant others, and the media to attain a thin body and three sub-scales that evaluate the desire to attain a lean body, to attain a muscular physique and overall concern with personal appearance. Participants rate their agreement with various statements on a 5-point scale.

    Measured: up to 72 hours after completion of the baseline assessment

  2. Ideal Body Stereotype Scale-Revised (IBSS-R)

    The IBSS-R measures the pursuit of the thin beauty ideal. Participants are asked to indicate to what extent they agree with six statements about what attractive women look like on a 5-point scale from strongly disagree to strongly agree. The total sum ranges from 0 to 30 with higher scores indicating a stronger internalization of the thin ideal.

    Measured: up to 72 hours after completion of the baseline assessment

  3. Body Parts Dissatisfaction Scale (BPDS)

    The BPDS assesses body dissatisfaction by asking the respondents to rate their satisfaction with 9 body parts on a scale from 1 (extremely dissatisfied) to 5 (extremely satisfied). Lower scores represent greater body dissatisfaction.

    Measured: up to 72 hours after completion of the baseline assessment

  4. Body mass index (BMI)

    Weight and height data will be collected via self-report in order to calculate BMI (kg/cm2).

    Measured: up to 72 hours after completion of the baseline assessment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Dec 2021
  2. Study start1 Dec 2021
  3. Primary completion15 Jun 2022
  4. Study completion15 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
64 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05144906
Sponsor's protocol ID
493-20
Status last verified
Nov 2021
First submitted
17 Nov 2021
Last updated
6 Jul 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The study will provide open access for de-identified data as well as for the analytical plan and protocol.

Questions about this trial

What is this clinical trial studying?

An observational study of Blindness and Implicit Bias, run by University of Haifa at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Implicit Association Test (time frame: One assessment at baseline after study information and informed consent was given). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in